Investigation of characterization and cytotoxic effect of PEGylated nanoliposomal containing Melphalan on ovarian cancer: an in vitro study

References

• Doun SKB, Alavi SE, Esfahani MKM, et al. Efficacy of Cisplatin-loaded poly butyl cyanoacrylate nanoparticles on the ovarian cancer: an in vitro study. Tumour Biol. 2014;35(8):7491–7497.
   PubMedGoogle Scholar
• Turner TB, Meza-Perez S, Londoño A, et al. Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth. Oncotarget. 2017;8(27):44159–44170.
   PubMedGoogle Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Klymenko Y, Johnson J, Bos B, et al. Heterogeneous cadherin expression and multicellular aggregate dynamics in ovarian cancer dissemination. Neoplasia. 2017;19(7):549–563.
   PubMed Web of Science ®Google Scholar
• Koohi Moftakhari Esfahani M, Alavi SE, Shahbazian S, et al. Drug delivery of cisplatin to breast cancer by polybutylcyanoacrylate nanoparticles. Adv Polym Technol. 2018;37(3):674–678.
   Web of Science ®Google Scholar
• Yingchoncharoen P, Kalinowski DS, Richardson DR. Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come. Pharmacol Rev. 2016;68(3):701–787.
   PubMed Web of Science ®Google Scholar
• Alavi SE, Muflih Al Harthi S, Ebrahimi Shahmabadi H, et al. Cisplatin-loaded polybutylcyanoacrylate nanoparticles with improved properties as an anticancer agent. Int J Mol Sci. 2019;20(7):1531.
   PubMed Web of Science ®Google Scholar
• Child JA, Morgan GJ, Davies FE, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med. 2003;348(19):1875–1883.
   PubMed Web of Science ®Google Scholar
• Ghaferi M, Koohi Moftakhari Esfahani M, Raza A, et al. Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances. J Drug Target. 2020;29(2):131–154.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science. 2004;303(5665):1818–1822.
   PubMed Web of Science ®Google Scholar
• Caruso G, Caffo M, Alafaci C, et al. Could nanoparticle systems have a role in the treatment of cerebral gliomas? Nanomedicine. 2011;7(6):744–752.
   PubMed Web of Science ®Google Scholar
• Ghaferi M, Asadollahzadeh MJ, Akbarzadeh A, et al. Enhanced efficacy of PEGylated liposomal cisplatin: In vitro and in vivo evaluation. Int J Mol Sci. 2020;21(2):559.
   PubMed Web of Science ®Google Scholar
• Al Harthi S, Alavi SE, Radwan MA, et al. Nasal delivery of donepezil HCl-loaded hydrogels for the treatment of Alzheimer’s disease. Sci Rep. 2019;9(1):1–20.
   PubMedGoogle Scholar
• Madni A, Sarfraz M, Rehman M, et al. Liposomal drug delivery: a versatile platform for challenging clinical applications. J Pharm Pharm Sci. 2014;17(3):401–426.
   PubMed Web of Science ®Google Scholar
• Alavi SE, Cabot PJ, Moyle PM. Glucagon-like peptide-1 receptor agonists and strategies to improve their efficiency. Mol Pharm. 2019;16(6):2278–2295.
   PubMedGoogle Scholar
• Ghafari M, Haghiralsadat F, Khanamani Falahati‐Pour S, et al. Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy. J Cell Biochem. 2020;121(7):3584–3592.
   PubMed Web of Science ®Google Scholar
• Ghaferi M, Amari S, Mohrir BV, et al. Preparation, characterization, and evaluation of cisplatin-loaded polybutylcyanoacrylate nanoparticles with improved in vitro and in vivo anticancer activities. Pharmaceuticals. 2020;13(3):44.
   Web of Science ®Google Scholar
• Na K, Lee SA, Jung SH, et al. Elastin-like polypeptide modified liposomes for enhancing cellular uptake into tumor cells. Colloids Surf B Biointerfaces. 2012;91:130–136.
   PubMed Web of Science ®Google Scholar
• Gayam SR, Venkatesan P, Sung Y-M, et al. An NAD(P)H:quinone oxidoreductase 1 (NQO1) enzyme responsive nanocarrier based on mesoporous silica nanoparticles for tumor targeted drug delivery in vitro and in vivo. Nanoscale. 2016;8(24):12307–12317.
   PubMed Web of Science ®Google Scholar
• Catanzaro D, Nicolosi S, Cocetta V, et al. Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells. Oncotarget. 2018;9(24):16847–16860.
   PubMedGoogle Scholar
• Andrieux K, Couvreur P. Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood–brain barrier. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1(5):463–474.
   PubMed Web of Science ®Google Scholar
• Bangham AD, Horne R. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol. 1964;8(5):660–IN10.
   PubMed Web of Science ®Google Scholar
• Alavi SE, Cabot PJ, Yap GY, et al. Optimized methods for the production and bioconjugation of site-specific, alkyne-modified glucagon-like peptide-1 (GLP-1) analogs to azide-modified delivery platforms using copper-catalyzed alkyne-azide cycloaddition. Bioconjug Chem. 2020;31(7):1820–1834.
   PubMed Web of Science ®Google Scholar
• Lee BK, Yun YH, Park K. Smart nanoparticles for drug delivery: boundaries and opportunities. Chem Eng Sci. 2015;125:158–164.
   PubMed Web of Science ®Google Scholar
• Martins S, Tho I, Ferreira D, et al. Physicochemical properties of lipid nanoparticles: effect of lipid and surfactant composition. Drug Dev Ind Pharm. 2011;37(7):815–824.
   PubMed Web of Science ®Google Scholar
• Nandhakumar S, Dhanaraju MD, Sundar VD, et al. Influence of surface charge on the in vitro protein adsorption and cell cytotoxicity of paclitaxel loaded poly (ε-caprolactone) nanoparticles. Bull Fac Pharm Cairo Univ. 2017;55(2):249–258.
   Google Scholar
• Naseripour M, Abrishami M, Sedaghat A, et al. Preparation and in vivo evaluation of nanoliposomes containing melphalan after intravitreal injection in albino rabbits. J Pharm Invest. 2016;46(6):575–582.
   Google Scholar
• Echeverri-Cuartas CE, Gartner C, Lapitsky Y. PEGylation and folate conjugation effects on the stability of chitosan-tripolyphosphate nanoparticles. Int J Biol Macromol. 2020;158:1055–1065.
   PubMed Web of Science ®Google Scholar
• Kouchakzadeh H, Shojaosadati SA, Maghsoudi A, et al. Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology. AAPS PharmSciTech. 2010;11(3):1206–1211.
   PubMed Web of Science ®Google Scholar
• Li D, Lu B, Huang Z, et al. A novel melphalan polymeric prodrug: preparation and property study. Carbohydr Polym. 2014;111:928–935.
   PubMed Web of Science ®Google Scholar
• Mishra PR, Al Shaal L, Müller RH, et al. Production and characterization of hesperetin nanosuspensions for dermal delivery. Int J Pharm. 2009;371(1-2):182–189.
   PubMed Web of Science ®Google Scholar
• Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev. 2003;55(3):403–419.
   PubMed Web of Science ®Google Scholar
• Soltani M, Chen P. Effect of tumor shape and size on drug delivery to solid tumors. J Biol Eng. 2012;6(1):4.
   PubMed Web of Science ®Google Scholar
• Izadi M, Ebrahimi Shahemabadi H, Kanaani L. Investigation of characteristics of loaded carboplatin on the liposomal nanoparticles on the cell carcinoma of the human brain c6. Adv Biores. 2016;7(4):113–118.
   Google Scholar
• Mehrabi M, Esmaeilpour P, Akbarzadeh A, et al. Efficacy of pegylated liposomal etoposide nanoparticles on breast cancer cell lines. Turk J Med Sci. 2016;46(2):567–571.
   PubMed Web of Science ®Google Scholar
• Cotter T, Lennon S, Glynn J, et al. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells. Anticancer Res. 1990;10(5A):1153–1159.
   PubMed Web of Science ®Google Scholar
• Darzynkiewicz Z, Bruno S, Del Bino G, et al. Features of apoptotic cells measured by flow cytometry. Cytometry. 1992;13(8):795–808.
   PubMedGoogle Scholar
• Chiani M, Norouzian D, Shokrgozar MA, et al. Folic acid conjugated nanoliposomes as promising carriers for targeted delivery of bleomycin. Artif Cells Nanomed Biotechnol. 2018;46(4):757–763.
   PubMed Web of Science ®Google Scholar
• Dadgar N, Esfahani MKM, Torabi S, et al. Effects of nanoliposomal and pegylated nanoliposomal artemisinin in treatment of breast cancer. Indian J Clin Biochem. 2014;29(4):501–504.
   PubMedGoogle Scholar
• Hwang T-L, Lee W-R, Hua S-C, et al. Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas. J Dermatol Sci. 2007;46(1):11–20.
   PubMed Web of Science ®Google Scholar